MicroRNA
Title:Meet Our Editor:
Volume: 4 Issue: 1
Author(s): Alberto Izzotti
Affiliation:
Export Options
About this article
Cite this article as:
Izzotti Alberto, Meet Our Editor:, MicroRNA 2015; 4 (1) . https://dx.doi.org/10.2174/221153660401150903113229
DOI https://dx.doi.org/10.2174/221153660401150903113229 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |
20
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Biological Effects of Diagnostic Cardiac Imaging
Current Pharmaceutical Design Statins and Cancer
Anti-Cancer Agents in Medicinal Chemistry Immune Responses to Gene Product of Inducible Promoters
Current Gene Therapy Crosstalk between IGF-1R and other Tumor Promoting Pathways
Current Pharmaceutical Design Acute Lymphoblastic Leukemia and Regulatory T cells: Biomarkers and Immunopathogenesis
Current Immunology Reviews (Discontinued) Repeated Transarterial Chemoembolization with Degradable Starch Microspheres (DSMs-TACE) of Unresectable Hepatocellular Carcinoma: A Prospective Pilot Study
Current Medical Imaging IP6 & Inositol in Cancer Prevention and Therapy
Current Cancer Therapy Reviews CD45 Regulated Signaling Pathways
Current Topics in Medicinal Chemistry Recent Progress in Delivery of Therapeutic and Imaging Agents Utilizing Organic-Inorganic Hybrid Nanoparticles
Current Drug Delivery Histamine and Histamine Receptor Antagonists in Cancer Biology
Inflammation & Allergy - Drug Targets (Discontinued) The Cancer Preventive Effects of Edible Mushrooms
Anti-Cancer Agents in Medicinal Chemistry Gene Expression Profiling in Rodent Models for Schizophrenia
Current Neuropharmacology Targeting the Ataxia Telangiectasia Mutated Protein in Cancer Therapy
Current Drug Targets VEGF Signaling in Cancer Treatment
Current Pharmaceutical Design Marine Microbes-Derived Anti-Bacterial Agents
Mini-Reviews in Medicinal Chemistry Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy
Current Medicinal Chemistry P-glycoprotein Inhibition: The Past, the Present and the Future
Current Drug Metabolism Hydrophilic Carotenoid Amphiphiles: Methods of Synthesis and Biological Applications
Mini-Reviews in Medicinal Chemistry Drugs that Inhibit Tubulin Polymerization: The Particular Case of Podophyllotoxin and Analogues
Current Medicinal Chemistry - Anti-Cancer Agents HIV-1 Vif: HIVs Weapon Against the Cellular Defense Factor APOBEC3G
Current HIV Research